Public signalReal estateAuto-indexed · Unverified
NexPoint Life Sciences II DST raised $39.6M
NexPoint Life Sciences II DST· DALLAS, US· Other Real Estate· Filed Nov 7, 2025
NexPoint Life Sciences II DST reported raising capital. Based in DALLAS, TEXAS, US. First sale reported 2023-06-20. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$39.6M
Confidence90%
Raised
$39.6M
Investors
109
Incorporated
2023
Jurisdiction
DELAWARE
On the record
- Location
- DALLAS, US
- Sector
- Other Real Estate
- Record type
- Real estate
- Stage
- Reported raised
- Amount raised
- $39.6M
- Target amount
- $40.5M
- Filing date
- Nov 7, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Year incorporated
- 2023
- Industry group
- Other Real Estate
- Number of investors
- 109
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $40.5M
- Amendment
- Yes
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 39,563,756 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Nov 7, 2025. Details beyond the filing have not been verified.
Tags
AmendmentUSCompanyOther Real Estate$10M – $100MReal Estate
Are you associated with NexPoint Life Sciences II DST?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record